World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
46461
World Ranking
7265
National Ranking
3806

Overview

Alex A. Adjei is affiliated with the Cleveland Clinic in the United States and has a substantial publication record in the field of medicine, with a particular focus on oncology and pulmonary and respiratory medicine. Their academic work spans multiple closely related areas, including molecular biology, radiology, nuclear medicine, imaging, and cancer research.

Their research topics cover a diverse range of subjects, notably:

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • Neuroendocrine Tumor Research Advances

Frequent coauthors who have collaborated extensively with Alex A. Adjei include Wen Wee, Jordi Remón, Konstantinos Leventakos, Aaron S. Mansfield, and Sumithra J. Mandrekar.

Many of their publications appear in prominent medical journals, with recurring contributions to:

  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Clinical Lung Cancer
  • Annals of Oncology
  • ESMO Open

Significant recent papers featuring Alex A. Adjei's work include:

  • Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals (2020), published in Critical Care Medicine
  • KRAS: From undruggable to a druggable Cancer Target (2020), published in Cancer Treatment Reviews
  • Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future Approaches (2020), published in Journal of Thoracic Oncology
  • Biomarker Discovery and Validation: Statistical Considerations (2021), published in Journal of Thoracic Oncology
  • Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations (2020), published in Journal of Thoracic Oncology

Best Publications

  • Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

    Julian R. Molina;Ping Yang;Stephen D. Cassivi;Steven E. Schild

  • Targeting apoptosis pathways in cancer therapy.

    Irene M. Ghobrial;Thomas E. Witzig;Alex A. Adjei

  • Blocking oncogenic Ras signaling for cancer therapy.

    Alex A. Adjei

  • Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin

    Ronald S. Go;Alex A. Adjei

  • Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers

    Alex A. Adjei;Roger B. Cohen;Wilbur Franklin;Clive Morris

  • Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    M Reck;S Popat;N Reinmuth;Dirk De Ruysscher

  • Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals

    David J. Lederer;Scott C. Bell;Richard D. Branson;James D. Chalmers

  • Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor

    Yujie Zhao;Alex A. Adjei

  • Small Cell Lung Cancer

    Taimur Sher;Grace K. Dy;Alex A. Adjei

  • Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

    Patricia M. LoRusso;Alex A. Adjei;Mary Varterasian;Shirish Gadgeel

  • A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

    Andrew M Scott;Greg Wiseman;Sydney Welt;Alex Adjei

  • Advances in Targeting the Ras/Raf/MEK/Erk Mitogen-Activated Protein Kinase Cascade with MEK Inhibitors for Cancer Therapy

    Bret B. Friday;Alex A. Adjei

  • Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003.

    Ping Yang;Mark S. Allen;Marie C. Aubry;Jason A. Wampfler

  • 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    J. Vansteenkiste;L. Crinò;C. Dooms;J. Y. Douillard

  • The clinical development of MEK inhibitors

    Yujie Zhao;Alex A. Adjei

  • 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

    W.E.E. Eberhardt;D. De Ruysscher;W. Weder;C. Le Péchoux

  • Novel Agents on the Horizon for Cancer Therapy

    Wen W. Ma;Alex A. Adjei

  • Understanding, recognizing, and managing toxicities of targeted anticancer therapies.

    Grace K. Dy;Alex A. Adjei

  • Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer

    Matthew P. Goetz;David Toft;Joel Reid;Matthew Ames

  • The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006.

    Chunrong Yu;Laura M Bruzek;Xue Wei Meng;Gregory J Gores

Frequent Co-Authors

Steven E. Schild
Steven E. Schild Mayo Clinic
James R. Jett
James R. Jett Mayo Clinic
Jeff A. Sloan
Jeff A. Sloan Mayo Clinic
David R. Gandara
David R. Gandara University of California, Davis
Solange Peters
Solange Peters University Hospital of Lausanne
Everett E. Vokes
Everett E. Vokes University of Chicago
Heather A. Wakelee
Heather A. Wakelee Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Medicine in the USA, there are several online degree options that can open alternative career pathways in healthcare. Many aspiring nurses and healthcare professionals now opt for distance learning due to its flexibility and convenience.

For registered nurses aiming to advance their qualifications, there are best online rn to bsn programs without clinical requirements. These programs let you earn a Bachelor of Science in Nursing without the need for in-person clinicals, making it easier to balance studies with work or family commitments.

If you’re planning to take your career further, you may look into a Doctor of Nursing Practice degree. There are options for both the shortest dnp program online—designed for those who want to complete their doctorate quickly—and more traditional dnp programs that cater to a wider range of learning paces and backgrounds.

For those just starting their nursing careers, you might consider online lpn programs. These fast-track options help you become a Licensed Practical Nurse, directly entering the workforce in a short time.

Exploring these related online degrees can give you greater flexibility and help you reach your healthcare career goals more efficiently.

Best Scientists Citing Alex A. Adjei

Trending Scientists

Recently Published Articles